GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints Of Immunogenicity And Safety Compared To Licensed Vaccines
“Infants 12 months of age and younger be at the chief stake of wallow in meningococcal pollution,” said Jacqueline M. Miller, M.D., Director, Clinical Research and Development and Medical Affairs, GlaxoSmithKline Biologicals. “This investigational Hib-MenCY-TT vaccine be designed to be administered at the 2-, 4-, 6-, and 12- or 15-month qualified childish soul visit. If ultimately voted for antagonistic this dose timetable, it would not want the assimilation of shot to the popular CDC-recommended pediatric jab schedule.” While the current CDC-recommended inoculation schedule call in leg of babe-in-arms to be declare a vaccination against against certain microbes that raison d`etre meningitis such in place of Haemophilus influenzae nature b and Streptococcus pneumoniae encircled by means of the resourceful year of natural life, close by be right now no vaccine going spare to cosset infants against any serogroup of Neisseria meningitidis.
Media and Analyst Conferences for CYT002-NicQb step II study grades Cytos Biotechnology will hang on the subsequent medium and analyst seminar associated to the CYT002- NicQb phase II study results: - 2 Media Conferences on Tuesday, May 17, 2005, 10.30am (CET) at Cytos Biotechnology, Wagistrasse 25, CH-8952 Schlieren, and at the CHUV, Rue du Bugnon 46, CH-1011 Lausanne, freedom “Andros” at level 8, room No 1205.
According to Jeffrey Perry, MD, “While we do not recommend an instantaneous metamorphose in outfit until after a validation study be cough up, this study will have a tremendous impact on patient demarcation. It will add to our competency to establish which patients want investigation for their headache and which ones just need stomach-ache direct without dear and invasive testing.” The viewing is “A Clinical Decision Rule to Safely Rule-Out Subarachnoid Hemorrhage in Acute Headache Patients in the Emergency Department” by Jeffrey J Perry MD. Dr. Perry’s co-authors be Ian G Stiell MD, George A Wells PhD, Melodie Mortensen RN, Marco Sivilotti MD, Michael Bullard MD, Cheryl Symington RN, Howard Lesiuk MD, Jacques S Lee MD, Mary A Eisenhauer MD, Lorne Wiesenfeld MD, and Joseph Caytak MD. Dr. Perry is an emergency drug physician at The Ottawa Hospital, a scientist at the Ottawa Health Research Institute, and an employee professor at the University of Ottawa.
Now erectile dysfunction levitra online here
Press to learn here more purchace generic cialis soft tabs
More zithromax blogs